Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Rocket Pharmaceuticals

Rocket Pharmaceuticals
2015 FOUNDED
PUBLIC STATUS
41-50 EMPLOYEES
RCKT STOCK SYMBOL
1 INVESTMENTS
$13.30 SHARE PRICE (As of Friday Closing)
Description

Rocket Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is involved in the business of discovery, development, and commercialization of therapies for diseases of the eye, primarily Glaucoma. Its main product candidate is Trabodenoson monotherapy. The company's product pipeline includes Trabodenoson monotherapy in an eye drop formulation and also trabodenoson plus latanoprost in an eye drop formulation.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
NAS
Primary Office
  • The Empire State Building, 350 Fifth Avenue
  • Suite 7530
  • New York, NY 10118
  • United States

+1 (646) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Rocket Pharmaceuticals’s full profile, request a free trial.

Rocket Pharmaceuticals Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$10.75 - $20.79 $670M $13.03 -$1.88 252K 50.3M

Rocket Pharmaceuticals Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 603,110 564,016 17,316 75,514
Revenue 0 0 0 0
EBITDA (77,295) (69,839) (26,537) (41,710)
Net Income (81,539) (74,518) (29,497) (42,854)
Total Assets 308,720 251,313 101,778 129,647
Total Debt 46,026 41,447 49,541 48,960
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Rocket Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Rocket Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Rocket Pharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000000 04-Jan-2018 000000000000000000 Drug Discovery 000000 0000 00
To view this company’s complete investment and acquisition history, request access »

Rocket Pharmaceuticals Subsidiaries (1)

Company Name Industry Location Founded
000000 00000000000 Drug Discovery Lexington, MA 0000
To view this company’s complete subsidiary history, request access »

Rocket Pharmaceuticals Executive Team (8)

Name Title Board
Seat
Contact
Info
Gaurav Shah MD Chief Executive Officer & Board Member
John Militello Chief Financial Officer & Chief Accounting Officer
Kinnari Patel Chief Operating Officer & Executive
Raj Prabhakar Senior Vice President, Business Development & Operations
Jonathan Schwartz MD Chief Medical Officer

3 Former Executives

You’re viewing 5 of 8 executives. Get the full list »

Rocket Pharmaceuticals Board Members (7)

Name Representing Role Since Contact
Info
Carsten Boess Self Board Member 000 0000
David Southwell Inotek Pharmaceuticals Board Member 000 0000
Gaurav Shah MD Rocket Pharmaceuticals Chief Executive Officer & Board Member 000 0000
Gotham Makker MD Self Board Member 000 0000
Naveen Yalamanchi MD Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »